Daxor Corporation (DXR)
USD 8.2
(-0.97%)
USD 8.2
(-0.97%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 34.86 Million USD | 15.23% |
| 2022 | 30.26 Million USD | 21.13% |
| 2021 | 24.98 Million USD | 50.92% |
| 2020 | 16.55 Million USD | 16.56% |
| 2019 | 14.2 Million USD | -19.43% |
| 2018 | 17.62 Million USD | -8.72% |
| 2017 | 19.31 Million USD | -6.37% |
| 2016 | 20.62 Million USD | -1.29% |
| 2015 | 20.89 Million USD | -54.63% |
| 2014 | 46.04 Million USD | -2.84% |
| 2013 | 47.39 Million USD | -15.86% |
| 2012 | 56.33 Million USD | -34.29% |
| 2011 | 85.72 Million USD | -6.0% |
| 2010 | 91.19 Million USD | 21.29% |
| 2009 | 75.18 Million USD | -2.13% |
| 2008 | 76.82 Million USD | -25.09% |
| 2007 | 102.56 Million USD | 31.21% |
| 2006 | 78.16 Million USD | 31.23% |
| 2005 | 59.56 Million USD | 6.5% |
| 2004 | 55.92 Million USD | 15.79% |
| 2003 | 48.3 Million USD | 16.18% |
| 2002 | 41.57 Million USD | -4.52% |
| 2001 | 43.54 Million USD | -12.17% |
| 2000 | 49.57 Million USD | 38.3% |
| 1999 | 35.84 Million USD | -18.72% |
| 1998 | 44.1 Million USD | 6.78% |
| 1997 | 41.3 Million USD | 10.72% |
| 1996 | 37.3 Million USD | -1.06% |
| 1995 | 37.7 Million USD | 7.71% |
| 1994 | 35 Million USD | 20.27% |
| 1993 | 29.1 Million USD | -10.74% |
| 1992 | 32.6 Million USD | 11.64% |
| 1991 | 29.2 Million USD | -9.03% |
| 1990 | 32.1 Million USD | 21.13% |
| 1989 | 26.5 Million USD | -12.54% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 34.37 Million USD | 0.0% |
| 2024 Q1 | 34.37 Million USD | -1.42% |
| 2023 Q3 | 34.86 Million USD | 14.86% |
| 2023 Q2 | 30.35 Million USD | 0.0% |
| 2023 Q1 | 30.35 Million USD | 0.32% |
| 2023 Q4 | 34.86 Million USD | 0.0% |
| 2023 FY | 34.86 Million USD | 15.23% |
| 2022 FY | 30.26 Million USD | 21.13% |
| 2022 Q2 | 22.43 Million USD | 0.0% |
| 2022 Q4 | 30.26 Million USD | 0.0% |
| 2022 Q3 | 30.26 Million USD | 34.91% |
| 2022 Q1 | 22.43 Million USD | -10.21% |
| 2021 Q1 | 16.65 Million USD | 0.6% |
| 2021 FY | 24.98 Million USD | 50.92% |
| 2021 Q2 | 16.65 Million USD | 0.0% |
| 2021 Q3 | 24.98 Million USD | 50.01% |
| 2021 Q4 | 24.98 Million USD | 0.0% |
| 2020 Q3 | 16.55 Million USD | 10.3% |
| 2020 FY | 16.55 Million USD | 16.56% |
| 2020 Q4 | 16.55 Million USD | 0.0% |
| 2020 Q1 | 15 Million USD | 5.68% |
| 2020 Q2 | 15 Million USD | 0.0% |
| 2019 Q3 | 14.2 Million USD | -21.11% |
| 2019 FY | 14.2 Million USD | -19.43% |
| 2019 Q1 | 18 Million USD | 2.13% |
| 2019 Q2 | 18 Million USD | 0.0% |
| 2019 Q4 | 14.2 Million USD | 0.0% |
| 2018 Q1 | 17.56 Million USD | -9.04% |
| 2018 FY | 17.62 Million USD | -8.72% |
| 2018 Q4 | 17.62 Million USD | 0.0% |
| 2018 Q3 | 17.62 Million USD | 0.35% |
| 2018 Q2 | 17.56 Million USD | 0.0% |
| 2017 Q1 | 20.74 Million USD | 0.57% |
| 2017 Q2 | 20.74 Million USD | 0.0% |
| 2017 Q3 | 19.31 Million USD | -6.9% |
| 2017 Q4 | 19.31 Million USD | 0.0% |
| 2017 FY | 19.31 Million USD | -6.37% |
| 2016 Q3 | 20.62 Million USD | -1.15% |
| 2016 Q4 | 20.62 Million USD | 0.0% |
| 2016 Q1 | 20.86 Million USD | -0.14% |
| 2016 Q2 | 20.86 Million USD | 0.0% |
| 2016 FY | 20.62 Million USD | -1.29% |
| 2015 Q3 | 20.89 Million USD | -32.89% |
| 2015 Q2 | 31.13 Million USD | 0.0% |
| 2015 Q1 | 31.13 Million USD | -32.38% |
| 2015 Q4 | 20.89 Million USD | 0.0% |
| 2015 FY | 20.89 Million USD | -54.63% |
| 2014 Q1 | 45.11 Million USD | -4.81% |
| 2014 Q2 | 45.11 Million USD | 0.0% |
| 2014 FY | 46.04 Million USD | -2.84% |
| 2014 Q3 | 46.04 Million USD | 2.06% |
| 2014 Q4 | 46.04 Million USD | 0.0% |
| 2013 Q3 | 47.39 Million USD | -9.45% |
| 2013 Q2 | 52.33 Million USD | 0.0% |
| 2013 FY | 47.39 Million USD | -15.86% |
| 2013 Q1 | 52.33 Million USD | -7.08% |
| 2013 Q4 | 47.39 Million USD | 0.0% |
| 2012 FY | 56.33 Million USD | -34.29% |
| 2012 Q4 | 56.33 Million USD | 0.0% |
| 2012 Q3 | 56.33 Million USD | 0.0% |
| 2011 Q3 | 88.25 Million USD | -8.3% |
| 2011 FY | 85.72 Million USD | -6.0% |
| 2011 Q4 | 85.72 Million USD | -2.86% |
| 2011 Q1 | 92.66 Million USD | 1.61% |
| 2011 Q2 | 96.23 Million USD | 3.85% |
| 2010 FY | 91.19 Million USD | 21.29% |
| 2010 Q3 | 86.24 Million USD | 7.51% |
| 2010 Q2 | 80.22 Million USD | -7.79% |
| 2010 Q1 | 86.99 Million USD | 15.71% |
| 2010 Q4 | 91.19 Million USD | 5.74% |
| 2009 Q2 | 74.91 Million USD | 20.13% |
| 2009 FY | 75.18 Million USD | -2.13% |
| 2009 Q1 | 62.36 Million USD | -18.82% |
| 2009 Q3 | 79.55 Million USD | 6.19% |
| 2009 Q4 | 75.18 Million USD | -5.49% |
| 2008 FY | 76.82 Million USD | -25.09% |
| 2008 Q4 | 76.82 Million USD | -16.28% |
| 2008 Q3 | 91.76 Million USD | -12.0% |
| 2008 Q2 | 104.27 Million USD | 27.99% |
| 2008 Q1 | 81.47 Million USD | -20.56% |
| 2007 Q2 | 80.38 Million USD | -3.69% |
| 2007 Q3 | 82.77 Million USD | 2.97% |
| 2007 Q4 | 102.56 Million USD | 23.9% |
| 2007 FY | 102.56 Million USD | 31.21% |
| 2007 Q1 | 83.46 Million USD | 6.78% |
| 2006 FY | 78.16 Million USD | 31.23% |
| 2006 Q2 | 61.3 Million USD | 4.02% |
| 2006 Q1 | 58.93 Million USD | -1.05% |
| 2006 Q3 | 67.11 Million USD | 9.47% |
| 2006 Q4 | 78.16 Million USD | 16.47% |
| 2005 Q4 | 59.56 Million USD | -6.63% |
| 2005 Q2 | 62.5 Million USD | 10.4% |
| 2005 Q1 | 56.61 Million USD | 1.22% |
| 2005 FY | 59.56 Million USD | 6.5% |
| 2005 Q3 | 63.79 Million USD | 2.07% |
| 2004 Q4 | 55.92 Million USD | 7.22% |
| 2004 Q3 | 52.16 Million USD | 5.33% |
| 2004 FY | 55.92 Million USD | 15.79% |
| 2004 Q1 | 50.13 Million USD | 3.79% |
| 2004 Q2 | 49.52 Million USD | -1.21% |
| 2003 Q2 | 45.55 Million USD | 16.0% |
| 2003 FY | 48.3 Million USD | 16.18% |
| 2003 Q4 | 48.3 Million USD | 6.46% |
| 2003 Q3 | 45.37 Million USD | -0.41% |
| 2003 Q1 | 39.27 Million USD | -5.53% |
| 2002 Q2 | 43.5 Million USD | -6.18% |
| 2002 Q1 | 46.36 Million USD | 6.5% |
| 2002 Q3 | 38.41 Million USD | -11.7% |
| 2002 Q4 | 41.57 Million USD | 8.21% |
| 2002 FY | 41.57 Million USD | -4.52% |
| 2001 Q3 | 43.33 Million USD | -10.11% |
| 2001 Q2 | 48.2 Million USD | 1.44% |
| 2001 Q1 | 47.52 Million USD | -4.14% |
| 2001 FY | 43.54 Million USD | -12.17% |
| 2001 Q4 | 43.54 Million USD | 0.48% |
| 2000 Q3 | 46.57 Million USD | 22.6% |
| 2000 Q2 | 37.98 Million USD | 5.55% |
| 2000 Q1 | 35.99 Million USD | 0.4% |
| 2000 FY | 49.57 Million USD | 38.3% |
| 2000 Q4 | 49.57 Million USD | 6.44% |
| 1999 Q2 | 41.3 Million USD | 7.27% |
| 1999 FY | 35.84 Million USD | -18.72% |
| 1999 Q3 | 39 Million USD | -5.57% |
| 1999 Q4 | 35.84 Million USD | -8.09% |
| 1999 Q1 | 38.5 Million USD | -12.7% |
| 1998 Q3 | 43.2 Million USD | 2.86% |
| 1998 Q2 | 42 Million USD | -2.78% |
| 1998 FY | 44.1 Million USD | 6.78% |
| 1998 Q1 | 43.2 Million USD | 4.6% |
| 1998 Q4 | 44.1 Million USD | 2.08% |
| 1997 Q3 | 36.6 Million USD | 2.52% |
| 1997 Q2 | 35.7 Million USD | 1.42% |
| 1997 Q1 | 35.2 Million USD | -5.63% |
| 1997 FY | 41.3 Million USD | 10.72% |
| 1997 Q4 | 41.3 Million USD | 12.84% |
| 1996 Q2 | 35.4 Million USD | 0.28% |
| 1996 Q4 | 37.3 Million USD | 6.57% |
| 1996 Q3 | 35 Million USD | -1.13% |
| 1996 Q1 | 35.3 Million USD | -6.37% |
| 1996 FY | 37.3 Million USD | -1.06% |
| 1995 Q1 | 35.2 Million USD | 0.57% |
| 1995 FY | 37.7 Million USD | 7.71% |
| 1995 Q4 | 37.7 Million USD | -1.57% |
| 1995 Q3 | 38.3 Million USD | 5.8% |
| 1995 Q2 | 36.2 Million USD | 2.84% |
| 1994 FY | 35 Million USD | 20.27% |
| 1994 Q3 | 34 Million USD | -5.29% |
| 1994 Q1 | 38.3 Million USD | 31.62% |
| 1994 Q2 | 35.9 Million USD | -6.27% |
| 1994 Q4 | 35 Million USD | 2.94% |
| 1993 Q4 | 29.1 Million USD | -3.0% |
| 1993 Q3 | 30 Million USD | -0.66% |
| 1993 FY | 29.1 Million USD | -10.74% |
| 1993 Q1 | 30.7 Million USD | -5.83% |
| 1993 Q2 | 30.2 Million USD | -1.63% |
| 1992 Q4 | 32.6 Million USD | 5.16% |
| 1992 Q3 | 31 Million USD | -2.82% |
| 1992 FY | 32.6 Million USD | 11.64% |
| 1992 Q1 | 32.4 Million USD | 10.96% |
| 1992 Q2 | 31.9 Million USD | -1.54% |
| 1991 Q3 | 28.2 Million USD | 0.0% |
| 1991 Q4 | 29.2 Million USD | 3.55% |
| 1991 Q1 | 28.9 Million USD | -9.97% |
| 1991 FY | 29.2 Million USD | -9.03% |
| 1990 Q2 | 27.5 Million USD | 3.77% |
| 1990 Q3 | 27 Million USD | -1.82% |
| 1990 Q4 | 32.1 Million USD | 18.89% |
| 1990 Q1 | 26.5 Million USD | 0.0% |
| 1990 FY | 32.1 Million USD | 21.13% |
| 1989 FY | 26.5 Million USD | -12.54% |
| 1989 Q4 | 26.5 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 80.668% |
| AngioDynamics, Inc. | 317.67 Million USD | 89.024% |
| AtriCure, Inc. | 613.93 Million USD | 94.32% |
| Avinger, Inc. | 13.77 Million USD | -153.225% |
| Azenta, Inc. | 2.88 Billion USD | 98.792% |
| BioLife Solutions, Inc. | 412.71 Million USD | 91.551% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.701% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -20.579% |
| Femasys Inc. | 27.75 Million USD | -25.628% |
| GlucoTrack, Inc. | 4.9 Million USD | -610.89% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 74.616% |
| Hologic, Inc. | 9.15 Billion USD | 99.619% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.204% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.774% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -22.516% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 89.945% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -460.709% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -460.709% |
| Masimo Corporation | 3.04 Billion USD | 98.854% |
| Microbot Medical Inc. | 8.32 Million USD | -318.748% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 79.717% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 98.5% |
| Nephros, Inc. | 11.86 Million USD | -193.981% |
| NovoCure Limited | 1.14 Billion USD | 96.958% |
| NEXGEL, Inc. | 9.95 Million USD | -250.268% |
| NEXGEL, Inc. | 9.95 Million USD | -250.268% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 86.865% |
| OraSure Technologies, Inc. | 482.84 Million USD | 92.778% |
| Pro-Dex, Inc. | 54.21 Million USD | 35.678% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 42.653% |
| Predictive Oncology Inc. | 14.41 Million USD | -141.857% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -106.173% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.593% |
| Repligen Corporation | 2.82 Billion USD | 98.765% |
| Sanara MedTech Inc. | 73.87 Million USD | 52.797% |
| STAAR Surgical Company | 488.69 Million USD | 92.865% |
| Sharps Technology, Inc. | 11.78 Million USD | -195.77% |
| Utah Medical Products, Inc. | 135.45 Million USD | 74.258% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.527% |
| Jin Medical International Ltd. | 32.9 Million USD | -5.974% |